A detailed history of York Bridge Wealth Partners, LLC transactions in Biogen Inc. stock. As of the latest transaction made, York Bridge Wealth Partners, LLC holds 1,027 shares of BIIB stock, worth $153,043. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,027
Previous 1,030 0.29%
Holding current value
$153,043
Previous $275,000 3.27%
% of portfolio
0.07%
Previous 0.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$252.44 - $306.72 $757 - $920
-3 Reduced 0.29%
1,027 $0
Q2 2022

Jul 15, 2022

SELL
$187.54 - $223.02 $1,312 - $1,561
-7 Reduced 0.68%
1,030 $210,000
Q4 2021

Jan 19, 2022

SELL
$223.92 - $287.77 $671 - $863
-3 Reduced 0.29%
1,037 $249,000
Q3 2021

Oct 22, 2021

SELL
$282.99 - $369.05 $2,263 - $2,952
-8 Reduced 0.76%
1,040 $294,000
Q2 2021

Jul 22, 2021

SELL
$259.0 - $414.71 $1,295 - $2,073
-5 Reduced 0.47%
1,048 $363,000
Q1 2021

Apr 15, 2021

SELL
$242.95 - $284.63 $36,199 - $42,409
-149 Reduced 12.4%
1,053 $295,000
Q4 2020

Jan 19, 2021

SELL
$236.26 - $355.63 $14,884 - $22,404
-63 Reduced 4.98%
1,202 $294,000
Q3 2020

Oct 19, 2020

BUY
$264.77 - $305.71 $2,912 - $3,362
11 Added 0.88%
1,265 $359,000
Q2 2020

Jul 20, 2020

SELL
$258.66 - $342.55 $2,845 - $3,768
-11 Reduced 0.87%
1,254 $336,000
Q1 2020

Apr 16, 2020

SELL
$268.85 - $341.04 $137,920 - $174,953
-513 Reduced 28.85%
1,265 $400,000
Q4 2019

Jan 17, 2020

SELL
$220.06 - $304.07 $53,474 - $73,889
-243 Reduced 12.02%
1,778 $528,000
Q3 2019

Oct 21, 2019

SELL
$217.44 - $243.88 $20,874 - $23,412
-96 Reduced 4.53%
2,021 $471,000
Q2 2019

Jul 18, 2019

SELL
$219.29 - $241.72 $19,297 - $21,271
-88 Reduced 3.99%
2,117 $495,000
Q1 2019

May 09, 2019

SELL
$216.71 - $338.96 $9,968 - $15,592
-46 Reduced 2.04%
2,205 $521,000
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $58,206 - $73,724
-209 Reduced 8.5%
2,251 $677,000
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $25,241 - $33,009
-86 Reduced 3.38%
2,460 $867,000
Q2 2018

Aug 10, 2018

SELL
$257.52 - $306.91 $30,644 - $36,522
-119 Reduced 4.47%
2,546 $739,000
Q1 2018

May 15, 2018

BUY
$260.13 - $367.91 $4,682 - $6,622
18 Added 0.68%
2,665 $713,000
Q4 2017

Feb 12, 2018

SELL
$307.64 - $344.58 $91,676 - $102,684
-298 Reduced 10.12%
2,647 $869,000
Q3 2017

Oct 27, 2017

SELL
$281.15 - $329.69 $14,057 - $16,484
-50 Reduced 1.67%
2,945 $922,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,995
2,995 $816,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track York Bridge Wealth Partners, LLC Portfolio

Follow York Bridge Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.